Acceleron Pharma

Investors & Media

SEC Filings

Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
424B2

Form of prospectus filed in connection with primary offering of securities on a delayed basis

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13G/A

An amendment to the SC 13G filing

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML

Data provided by Kaleidoscope.